-
Canaccord Genuity Reiterates Buy Rating on Pulmonx Corp. (LUNG)
-
Pulmonx reappoints Glen French as CEO, reports Q3 revenue of $21.5 million
-
Pulmonx Corporation (LUNG) files $200M mixed shelf
-
Piper Sandler Downgrades Pulmonx Corp. (LUNG) to Neutral
-
Pulmonx Corporation (LUNG) Tops Q2 EPS by 2c
-
Stifel Reiterates Buy Rating on Pulmonx Corp. (LUNG)
-
Pulmonx Corp. (LUNG) PT Lowered to $15 at Canaccord Genuity
-
Pulmonx Corporation (LUNG) Tops Q1 EPS by 3c
-
Canaccord Genuity Reiterates Buy Rating on Pulmonx Corp. (LUNG)
-
D. Boral Capital Starts Pulmonx Corp. (LUNG) at Buy
-
EDAP TMS S.A. (EDAP) Appoints Glen French to its Board
-
Pulmonx Corp. (LUNG) PT Raised to $8 at Citi
-
Pulmonx Corporation (LUNG) Tops Q4 EPS by 12c
-
Citi Downgrades Pulmonx Corp. (LUNG) to Neutral
-
Pulmonx Corporation (LUNG) Tops Q3 EPS by 81c, provides guidance
-
Pulmonx Corp. (LUNG) PT Raised to $16 at Canaccord Genuity
-
Pulmonx Corporation (LUNG) Tops Q2 EPS by 3c

